Premium
Randomised clinical trial: macrogol/ PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation ‐ a comparison in a controlled environment
Author(s) -
Cinca R.,
Chera D.,
Gruss H.J.,
Halphen M.
Publication year - 2013
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12278
Subject(s) - medicine , constipation , peg ratio , defecation , population , gastroenterology , confidence interval , chronic constipation , environmental health , finance , economics
Constipation is a common condition for which PEG 3350 is an established treatment and prucalopride has recently been approved for this indication.